ARG66544

anti-MCM4 phospho (Ser54) antibody

anti-MCM4 phospho (Ser54) antibody for IHC-Formalin-fixed paraffin-embedded sections,Western blot and Human,Mouse,Monkey

Overview

Product Description Rabbit Polyclonal antibody recognizes MCM4 phospho (Ser54)
Tested Reactivity Hu, Ms, Mk
Tested Application IHC-P, WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name MCM4
Antigen Species Human
Immunogen Phosphospecific peptide around Ser54 of Human MCM4.
Conjugation Un-conjugated
Alternate Names DHP; DPD; DHPDHASE; Dihydropyrimidine dehydrogenase [NADP(+)]; DHPDHase; DPD; EC 1.3.1.2; Dihydrothymine dehydrogenase; Dihydrouracil dehydrogenase

Application Instructions

Application Suggestion
Tested Application Dilution
IHC-P1:100 - 1:300
WB1:500 - 1:2000
Application Note IHC-P: Antigen Retrieval: High-pressure and temperature Tris-EDTA buffer (pH 8.0).
* The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Affinity purification with immunogen.
Buffer PBS, 0.02% Sodium azide, 50% Glycerol and 0.5% BSA.
Preservative 0.02% Sodium azide
Stabilizer 50% Glycerol and 0.5% BSA
Concentration 1 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 1806 Human DPYD

GeneID: 99586 Mouse DPYD

Swiss-port # Q12882 Human Dihydropyrimidine dehydrogenase [NADP(+)]

Swiss-port # Q8CHR6 Mouse Dihydropyrimidine dehydrogenase [NADP(+)]

Gene Symbol DPYD
Gene Full Name dihydropyrimidine dehydrogenase
Background The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
Function Involved in pyrimidine base degradation. Catalyzes the reduction of uracil and thymine. Also involved the degradation of the chemotherapeutic drug 5-fluorouracil. [UniProt]
Cellular Localization Cytoplasm. [UniProt]
Calculated MW 111 kDa